Attenuation of Metabolic Syndrome by EPA/DHA Ethyl Esters in Testosterone-Deficient Obese Rats

Inducing testosterone deficiency, as the standard treatment of prostate cancer, may cause metabolic disorders including insulin resistance, dyslipidemia, central obesity, cardiovascular diseases, and type 2 diabetes. This study measured responses to testosterone deficiency in high-carbohydrate, high...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhandarkar, Nikhil S., Kumar, Senthil Arun, Martin, Jarad, Brown, Lindsay, Panchal, Sunil K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024942/
https://www.ncbi.nlm.nih.gov/pubmed/29794984
http://dx.doi.org/10.3390/md16060182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024942/
https://www.ncbi.nlm.nih.gov/pubmed/29794984
http://dx.doi.org/10.3390/md16060182

Ejemplares similares